|
News: Nanoparticles Deliver Gene Therapy Directly to Skin Cells
|
Scientists have developed an siRNA-carrying gold nanoparticle that they claim can be mixed with a commercial moisturizing cream to enable the topical delivery of gene-targeting therapeutics directly into deep skin layers. The Northwestern University team says the platform could lead to the development of topical forms of gene therapy for diseases such as skin cancer, inflammation, and genetic skin disorders.
Read more... |
|
News: Bluebird wins orphan drug designation for ALD treatment
|
Cambridge-based genetic disorder drug maker bluebird bio said today it has received an orphan drug designation from both the U.S. Food and Drug Administration and the European Medicines Agency for its investigational gene therapy designed to treat adrenoleukodystrophy. Known as ALD, adrenoleukodystrophy is a rare, inherited disorder that leads to progressive brain damage, failure of the adrenal glands and ultimately death. The company said it plans to initiate a Phase 2/3 clinical study in childhood cerebral ALD in both the U.S. and Europe next year.
Read more... |
|
Poll: Cancer gene therapy available in China |
Gene Therapy Net started a new poll regarding commercial cancer gene therapy treatments in Asia. There is still no gene therapy product on the market in the US and Europe, but there is a gene therapy cancer product available in China. Would you travel to China to receive this treatment? What do you think? Vote now!
1- Yes, immediately, or
2- Yes, but first consult my own doctor, or
3- No, I don't think it will work, or
4- No, I want treatment in my own country
Vote now... |
|
Conference: World Cord Blood Conference
|
The World Cord Blood Congress is North America’s leading commercial cord blood banking and therapy conference. The World Cord Blood Congress is where science and business come together to advance the cord blood banking and therapeutics sectors. Speakers include senior-level executives from private and public cord blood banks, hospitals, biotech companies, academia, and government.
Read more... |
|
Conference: Stem Cells USA Regenerative Medicine Congress
|
Stem Cells USA & Regenerative Medicine Congress is the region's largest commercial stem cells conference. Most stem cell companies face two options - go bankrupt or find a partner with deep pockets. Despite there being hundreds of companies with promising technologies, most of them never pass Phase II trials due to lack of funding. This year’s Stem Cells USA & Regenerative Medicine Congress will focus on strategies and business models to help you navigate this increasingly challenging marketplace, and to ensure your stem cell and regenerative medicine gets to market.
New to 2012 - this year's conference will take place alongside the World Cord Blood Congress. What does this mean for you? Double the networking and double the content.
Read more... |
|
Conferences
|
| - |
4 – 6 October 2012, International Society for Cell & Gene Therapy of Cancer - 2012 Singapore Conference, Singapore |
| - |
26 – 29 October 2012, European Society Of Gene & Cell Therapy (ESGCT) XXth annual meeting and the French Society of Cell and Gene Therapy (SFTCG) collaborative Congress 2012, Versailles, France |
| - |
19 – 21 November 2012, International Conference on Genetic Syndromes & Gene Therapy, San Antonio, USA |
| - |
5 - 7 December 2012, DNA Vaccines 2012, San Diego, LA |
| - |
28 - 30 January 2013, Phacilitate 9th Annual Cell & Gene Therapy Forum 2013, Washington DC, MD, |
| - |
17 - 19 April 2013, Annual conference of the British Society for Gene Therapy (BSGT), London, UK |
| - |
15 – 18 May 2013, American Society of Gene and Cell Therapy (ASGCT) 16th Annual Meeting, Salt Lake City, Utah |
Read more... |
|
|
